by Jane Schumacher | Aug 12, 2024
Drugmakers will receive flat fees for new medicines in push to avoid encouraging overuse The NHS will agree subscription-style deals with drugmakers for antibiotics, as the UK seeks to encourage the development of new medicines and curb antimicrobial resistance...
by Danny O'Keefe | Jul 3, 2024
Geneva – July 3rd, 2024 – The AMR Industry Alliance is pleased to attend the 10th Annual World AMR Congress in the lead-up to the UN High-Level Meeting on antimicrobial resistance. The Congress will be held on September 5-6, 2024, at the Pennsylvania Convention Center...
by Jane Schumacher | May 7, 2024
The Global AMR Diary to ignite awareness and catalyze action to shape policy and saves lives GENEVA — MAY 7, 2024 — The Partnership to Fight Infectious Disease (PFID) and a collective of influential global health leaders, including public and private...
by Danny O'Keefe | May 1, 2024
The AMR Industry Alliance released its Equitable & Responsible Access Roadmap highlighting key barriers to diagnostics and antimicrobial access — and outlining solutions to tackle the barriers of regulatory issues, demand forecasting, and procurement...
by Danny O'Keefe | Apr 29, 2024
Geneva – April 30, 2024 – A new report from the AMR Industry Alliance examines the role of diagnostics in national action plans (NAPs) and highlights successful examples integrating and implementing diagnostics into NAPs in LMICs to combat AMR. Based on a review of...
